Study of the HIV gp120/NefTat/AS02A Vaccine to Treat Individuals With Chronic HIV-1 Infection on Highly Active Antiretroviral Therapy (HAART)

NCT00117429 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDIV

Sponsor class

Conditions

HIV Infections

Interventions

BIOLOGICAL: HIV gp120/NefTat/AS02A Vaccine

Sponsor

Marcus Altfeld, M.D., Ph.D.

Collaborators

[object Object]